CompletedInterventionalPhase 2Last updated Mar 4, 2025

Use of 18F-PSMA-11 PET for Detection of Lesions in Iodine Refractory Thyroid Cancers

Overview

ClinicalTrials.gov ID: NCT05175404
Lead Sponsor: University Hospital, GhentOTHER
Brief Summary: Determine the diagnostic value of 18F-PSMA-11 in patients with iodine refractory thyroid cancer.
Study Type: Interventional

Status

Study Record Dates

NCT03196518Active, not recruiting

Study of PET Imaging With 18F-TFB in Patients With Thyroid Cancer

NCT05534594Completed

Evaluation of the 18F-PSMA Positron Emission Tomography (PET)/CT in Patients With Medullary Thyroid Cancer

NCT03647358Recruiting

Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma

NCT03463889Terminated

Gallium-68 Prostate Specific Membrane Antigen PET in Diagnosing Patients With Thyroid Cancer

NCT00647140Terminated

Clinical Evaluation of 18F-DOPA Positron Emission Tomography in Medullary Thyroid Cancer

NCT04927416Recruiting

The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer